National TCM master Liu Jiaxiang’s discourse on clinical research and medical ethics in traditional Chinese medicine

JIANG Yi; CHEN Xiaoyun; LIU Jiaxiang

doi:10.16305/j.1007-1334.2023.2211040

您当前的位置：

首页 >

文章列表页 >

National TCM master Liu Jiaxiang’s discourse on clinical research and medical ethics in traditional Chinese medicine

更新时间：2023-05-16

- National TCM master Liu Jiaxiang’s discourse on clinical research and medical ethics in traditional Chinese medicine
- Shanghai Journal of Traditional Chinese Medicine Vol. 57, Issue 5, Pages: 51-53(2023)
- 作者机构：
  
  1.上海中医药大学附属龙华医院肿瘤科（上海 200032）
  2.上海中医药大学附属龙华医院伦理办公室（上海 200032）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2023.2211040
  CLC：
扫描看全文
姜怡,陈晓云,刘嘉湘.国医大师刘嘉湘谈中医药临床研究与医学伦理[J].上海中医药杂志,2023,57(5):51-53.

JIANG Yi,CHEN Xiaoyun,LIU Jiaxiang.National TCM master Liu Jiaxiang’s discourse on clinical research and medical ethics in traditional Chinese medicine[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(5):51-53.
姜怡,陈晓云,刘嘉湘.国医大师刘嘉湘谈中医药临床研究与医学伦理[J].上海中医药杂志,2023,57(5):51-53. DOI： 10.16305/j.1007-1334.2023.2211040.

JIANG Yi,CHEN Xiaoyun,LIU Jiaxiang.National TCM master Liu Jiaxiang’s discourse on clinical research and medical ethics in traditional Chinese medicine[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(5):51-53. DOI： 10.16305/j.1007-1334.2023.2211040.

摘要

国医大师刘嘉湘教授从20世纪60年代起开展中医药治疗恶性肿瘤的临床研究，注重受试者的生存期、生活质量和用药权益，强调中医药临床研究的科学性、规范性和伦理性。系统阐述刘教授近60年以来在中医药临床研究中倡导、实践和推动医学伦理的举措，并介绍其严谨的临床研究医学伦理素养，为国内外中医药临床研究的实施和受试者的保护提供宝贵的经验。

Abstract

Professor Liu Jiaxiang， as one of the national traditional Chinese medicine （TCM） masters， has been conducting clinical research on the treatment of malignant tumors with TCM since the 1960s， focusing on the survival， quality of life， and rights and interests of subjects with medications， and emphasizing the scientific， normative and ethical aspects of clinical research in TCM. In this paper， we systematically describe Professor Liu’s initiatives in advocating， practicing and promoting medical ethics in TCM clinical research for nearly 60 years， and introduce his rigorous approach to medical ethics in clinical research， for the purpose of providing valuable experience for the implementation of TCM clinical research and the protection of subjects worldwide.

关键词

医学伦理临床研究循证医学中医药疗法肿瘤

Keywords

medical ethicsclinical researchevidence-based medicinetraditional Chinese medicine therapytumor

references

刘嘉湘. 中医辨证治疗支气管肺癌200例疗效观察［J］. 新医药学杂志，1977， 22（10）： 20-24， 49-50.

刘嘉湘. 中医辨证治疗原发性肺癌300例疗效分析（摘要）［J］. 浙江肿瘤通讯，1980， 6（3）： 67-68.

刘嘉湘. 辨证治疗原发性肺癌310例疗效分析［J］. 上海中医药杂志，1985， 20（10）： 3-6.

刘嘉湘. 中医扶正法治疗支气管肺癌的体会［J］. 新医药学杂志，1977， 22（10）： 17-19.

刘嘉湘. 扶正治癌融汇中西继承创新［J］. 中国中西医结合杂志，2019， 39（1）： 10-12.

刘嘉湘，徐振晔，施志明，等. 扶正法治疗122例晚期原发性非小细胞肺癌的前瞻性研究［J］. 中国医药学报，1987， 2（1）： 11-16.

刘嘉湘，施志明，徐振晔，等. 滋阴生津益气温阳法治疗晚期原发性肺腺癌的临床研究［J］.中医杂志，1995， 44（3）： 155-158， 132.

刘嘉湘，施志明，李和根，等. 益肺抗瘤饮治疗271例非小细胞肺癌临床观察［J］. 上海中医药杂志，2001， 35（2）： 4-6.

刘苓霜，张朋，姜怡，等. 中医扶正法治疗肺癌的临床疗效及其对机体的免疫调节作用［J］. 自然杂志，2019， 41（4）： 281-286.

刘嘉湘，施志明，徐振晔，等. 金复康口服液治疗非小细胞肺癌的临床观察［J］. 中医杂志，1997， 46（12）： 727-729，708.

刘嘉湘，潘敏求，黎月恒，等. 金复康口服液治疗原发性非小细胞肺癌临床研究［J］. 肿瘤，2001， 21（6）： 463-465.

刘嘉湘，施志明，赵丽红，等. 正得康在癌症治疗中扶正作用的研究［J］. 中医药学刊，2001， 19（5）： 423-425.

刘嘉湘，许德凤，范忠泽. 蟾酥膏缓解癌性疼痛的临床疗效观察［J］. 中医杂志，1993， 42（5）： 281-282.

刘嘉湘，田建辉. 传承中医药学术精华，促进肿瘤学创新发展［J］. 上海中医药杂志，2020， 54（7）： 29-33.

MCCULLOCH M， SEE C， SHU X J， et al. Astragalus-based Chinese herbs and platinum-based chemotherapy for advanced non-small-cell lung cancer： meta-analysis of randomized trials［J］. J Clin Oncol， 2006， 24（3）：419-430.

JIANG Y， LIU L S， SHEN L P， et al. Traditional Chinese medicine treatment as adjuvant therapy in completely resected stage IB-ⅢA non-small-cell lung cancer： study protocol for a multicenter， double-blind， randomized， placebo-controlled trial［J］. Clin Lung Cancer， 2019， 20（5）： e541-e547.

JIANG Y， LIU L S， SHEN L P， et al. Traditional Chinese medicine treatment as maintenance therapy in advanced non-small-cell lung cancer： A randomized controlled trial［J］. Complement Ther Med， 2016， 24：55-62.

Views

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical research progress on classic famous prescriptions combined cold and heat in treatment of malignant tumors

Thoughts on practice and management of clinical research of traditional Chinese medicine during normalization stage of prevention and control of COVID⁃19

Effects of Chaihu Shugan Powder on AMPK/SIRT3 signaling pathway in rats with functional dyspepsia

A randomized， double‑blind， placebo‑controlled clinical trial on the external application of Taohong Siwu Decoction to improve the arteriovenous fistula patency during hemodialysis

Liang Linjiang's experience in treating complex anal fistula

Related Author

No data

Related Institution

Department of Oncology， Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Graduate School， Shanghai University of Traditional Chinese Medicine

Key Laboratory of Liver and Kidney Diseases （Ministry of Education）， Institute of Liver Diseases ， Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Shanghai Municipal Hospital of Traditional Chinese Medicine， Shanghai University of Traditional Chinese Medicine

Gastroenterology Department，Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

⁰